Skip to main content

Articles

Page 1 of 15

  1. Opioid use disorder (OUD) as a common drug use disorder can affect public health issues, including the COVID-19 pandemic, in which patients with OUD may have higher risk of infection and severe disease. This s...

    Authors: Amir Hossein Behnoush, Elham Bazmi, Mehdi Forouzesh and Behnam Behnoush
    Citation: Addiction Science & Clinical Practice 2022 17:68
  2. People who use drugs (PWUD) are at high risk for hepatitis C virus (HCV) infection and its complications. Given the high prevalence rate of HCV in PWUD, the World Health Organization (WHO) emphasizes PWUD as a...

    Authors: Daan W. Von den Hoff, Floor A. C. Berden, Joost P. H. Drenth and Arnt F. A. Schellekens
    Citation: Addiction Science & Clinical Practice 2022 17:67
  3. Approximately 80% of people with a substance use disorder (SUD) are smokers. Starting SUD treatment offers the opportunity to also quit smoking. The ACT-ATAC project aims to identify the predictors associated ...

    Authors: Ariadna Feliu, Esteve Fernández, Yolanda Castellano, Marta Enríquez, Judith Saura, Carmen Cabezas, Joan Colom, Josep M. Suelves, Margarida Pla, Mar Parejo, Sílvia Mondon, Pablo Barrio, Magalí Andreu, Antonia Raich, Jordi Bernabeu, Jordi Vilaplana…
    Citation: Addiction Science & Clinical Practice 2022 17:66
  4. Efficient and linguistically appropriate instruments are needed to assess response to addiction treatment, including severity of addiction/mental health status. This is critical for Russian-speaking persons in...

    Authors: Lynn M. Madden, Scott O. Farnum, Daniel J. Bromberg, Declan T. Barry, Alyona Mazhnaya, Tetiana Fomenko, Anna Meteliuk, Ruthanne Marcus, Julia Rozanova, Iurii Poklad, Sergii Dvoriak and Frederick L. Altice
    Citation: Addiction Science & Clinical Practice 2022 17:65
  5. Alcohol use disorder (AUD) accounts for millions of acute care encounters annually in the United States. Hospitalization represents a vital opportunity to intervene pharmacologically, but low medication adhere...

    Authors: Dale Terasaki, Ryan Loh, Anastasia Cornell, Julie Taub and Christian Thurstone
    Citation: Addiction Science & Clinical Practice 2022 17:64
  6. Despite the proven efficacy of medications for opioid use disorder (MOUD) and recent reduction in barriers to prescribers, numerous obstacles exist for patients seeking MOUD. Prior studies have used telephone ...

    Authors: Alina Syros, Maria G. Rodriguez, Andrew C. Rennick, Grace A. Dima, Alexander R. Gibstein, Lauren de la Parte, Matthew G. Hermenau, Katrina J. Ciraldo, Teresa A. Chueng, Hansel E. Tookes, Tyler S. Bartholomew and David P. Serota
    Citation: Addiction Science & Clinical Practice 2022 17:63
  7. With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not addressed in...

    Authors: Brandon T. Sanford, Benjamin A. Toll, Allison Ross Eckard, Katherine R. Sterba, K. Michael Cummings, Nathaniel L. Baker and Alana M. Rojewski
    Citation: Addiction Science & Clinical Practice 2022 17:61
  8. Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including same-day MOUD ini...

    Authors: Jamie Carter, Zhen Li, Hillary Chen, Melissa Greiner, Christopher Bush, Debanjan Bhattacharya, Stephanie Poley, Nidhi Sachdeva, Jane Carolyn Crowder and Jacob Feigal
    Citation: Addiction Science & Clinical Practice 2022 17:60
  9. In recent years, pediatric emergency departments (PED) have seen an increase in presentations related to substance use among their adolescent patient population. We aimed to examine pediatric emergency medicin...

    Authors: Ariel M. Hoch, Samantha F. Schoenberger, Tehnaz P. Boyle, Scott E. Hadland, Mam Jarra Gai and Sarah M. Bagley
    Citation: Addiction Science & Clinical Practice 2022 17:59
  10. Injection drug use (IDU) remains the strongest risk factor for hepatitis C virus (HCV) in the United States. HCV rates are increasing in rural areas among young adult people who inject drugs (PWID). People wit...

    Authors: Akash Gupta, Fatma M. Shebl, Yao Tong, Katherine Wagner, Ingrid V. Bassett, Kimberly Page and Erin L. Winstanley
    Citation: Addiction Science & Clinical Practice 2022 17:58
  11. Hospitalizations involving opioid use disorder (OUD) have been increasing among Medicare beneficiaries of all ages. With rising OUD-related acute care use comes the need to understand where post-acute care is ...

    Authors: Patience Moyo, Melissa Eliot, Asghar Shah, Kimberly Goodyear, Eric Jutkowitz, Kali Thomas and Andrew R. Zullo
    Citation: Addiction Science & Clinical Practice 2022 17:57
  12. Up to 95% of pregnant women with alcohol and other drug (AOD) problems also smoke tobacco. Challenging psychosocial circumstances and a lack of targeted tobacco interventions contribute to low rates of prenata...

    Authors: Melissa A. Jackson, Penny Buykx, Amanda L. Brown, Amanda L. Baker, Adrian J. Dunlop and Gillian S. Gould
    Citation: Addiction Science & Clinical Practice 2022 17:56
  13. Novel buprenorphine dosing strategies have emerged with an aim to transition patients from opioid agonists to buprenorphine without prerequisite opioid withdrawal. We applied a configurational approach to a su...

    Authors: Adams K. K., Miech E. J. and Sobieraj D. M.
    Citation: Addiction Science & Clinical Practice 2022 17:55
  14. Alcohol consumption is a major public health challenge; the majority of employees consume alcohol regularly and a considerable proportion of employees can be characterized as risky drinkers in need of interven...

    Authors: Mikkel Magnus Thørrisen, Talieh Sadeghi, Tore Bonsaksen, Ian D. Graham and Randi Wågø Aas
    Citation: Addiction Science & Clinical Practice 2022 17:54
  15. Coupling social network visualizations with Motivational Interviewing in substance use interventions has been shown to be acceptable and feasible in several pilot tests, and has been associated with changes in...

    Authors: David P. Kennedy, Elizabeth J. D’Amico, Ryan A. Brown, Alina I. Palimaru, Daniel L. Dickerson, Carrie L. Johnson and Anthony Lopez
    Citation: Addiction Science & Clinical Practice 2022 17:53
  16. South Africa has the highest number of people with HIV (PWH) globally and a significant burden of co-occurring substance use disorder (SUD). Health care worker (HCW) stigma towards SUD is a key barrier to HIV ...

    Authors: Jessica F. Magidson, Alexandra L. Rose, Kristen S. Regenauer, Carrie Brooke-Sumner, Morgan S. Anvari, Helen E. Jack, Kim Johnson, Jennifer M. Belus, John Joska, Ingrid V. Bassett, Goodman Sibeko and Bronwyn Myers
    Citation: Addiction Science & Clinical Practice 2022 17:52
  17. Women with co-occurring posttraumatic stress disorder (PTSD) and substance use disorder (SUD) experience systemic barriers that place them in danger of poorer treatment outcomes. Some mindfulness-based interve...

    Authors: Vanessa C. Somohano, Josh Kaplan, Aurora G. Newman, Maya O’Neil and Travis Lovejoy
    Citation: Addiction Science & Clinical Practice 2022 17:51
  18. People with opioid use disorder (OUD) face barriers to entering and remaining in life-saving treatment (e.g., stigma, detrimental interactions with health care, and privacy concerns). Telehealth and related te...

    Authors: Jordon D. Bosse, Kim Hoffman, Katharina Wiest, P. Todd Korthuis, Ritwika Petluri, Kellie Pertl and Stephen A. Martin
    Citation: Addiction Science & Clinical Practice 2022 17:50
  19. There is an urgent need for interventions helping children affected by parental problematic alcohol consumption (PAC). Such interventions could target partners to individuals with PAC, partners who often thems...

    Authors: Ola Siljeholm, Philip Lindner, Magnus Johansson and Anders Hammarberg
    Citation: Addiction Science & Clinical Practice 2022 17:49
  20. People who inject drugs (PWID) have low rates of COVID-19 testing and vaccination and are vulnerable to severe disease. We partnered with a local, community-based syringe service program (SSP) in San Diego Cou...

    Authors: Angela R. Bazzi, Alicia Harvey-Vera, Tara Buesig-Stamos, Daniela Abramovitz, Carlos F. Vera, Irina Artamonova, Thomas L. Patterson and Steffanie A. Strathdee
    Citation: Addiction Science & Clinical Practice 2022 17:48
  21. Opioids are effective in pain-management, but long-term opioid users can develop prescription opioid use disorder (OUD). One treatment strategy in patients with OUD is rotating from a short-acting opioid to a ...

    Authors: Hannah Ellerbroek, Sandra A. S. van den Heuvel, Albert Dahan, Hans Timmerman, Cornelis Kramers and Arnt F. A. Schellekens
    Citation: Addiction Science & Clinical Practice 2022 17:47
  22. Post-traumatic stress disorder (PTSD) and substance use disorders (SUDs) often co-occur in adolescent patients. Previous research has shown that these patients differ from SUD patients without PTSD in terms of...

    Authors: Lukas Andreas Basedow, Melina Felicitas Wiedmann, Veit Roessner, Yulia Golub and Sören Kuitunen-Paul
    Citation: Addiction Science & Clinical Practice 2022 17:46
  23. Residential treatment is a common approach for treating opioid use disorder (OUD), however, few studies have directly compared it to outpatient treatment. The objective of this study was to compare OUD outcome...

    Authors: Daniel M. Hartung, Sheila Markwardt, Kirbee Johnston, Jonah Geddes, Robin Baker, Gillian Leichtling, Christi Hildebran, Brian Chan, Ryan R. Cook, Dennis McCarty, Udi Ghitza and P. Todd Korthuis
    Citation: Addiction Science & Clinical Practice 2022 17:45
  24. Psychosocial interventions are needed to enhance patient engagement and retention in medication treatment within opioid treatment programs. Measurement-based care (MBC), an evidence-based intervention structur...

    Authors: Kelli Scott, John Guigayoma, Lawrence A. Palinkas, Francesca L. Beaudoin, Melissa A. Clark and Sara J. Becker
    Citation: Addiction Science & Clinical Practice 2022 17:44
  25. Medications for opioid use disorder (MOUDs), including methadone, buprenorphine, and naltrexone, decrease mortality and morbidity for people with opioid use disorder (OUD). Buprenorphine and methadone have the...

    Authors: Barbara Andraka-Christou, Cory Page, Victoria Schoebel, Jessica Buche and Rebecca L. Haffajee
    Citation: Addiction Science & Clinical Practice 2022 17:43
  26. As a public health issue, non-fatal overdose (NFOD) is highly prevalent among people who inject drugs (PWID). This can lead to an elevated risk of future overdose, causing various harms including possible deat...

    Authors: Bahram Armoon, Mark D. Griffiths, Azadeh Bayani, Rasool Mohammadi and Elaheh Ahounbar
    Citation: Addiction Science & Clinical Practice 2022 17:42
  27. In an effort to address the current opioid epidemic, a number of hospitals across the United States have implemented emergency department-based interventions for engaging patients presenting with opioid use di...

    Authors: Dennis P. Watson, Monte D. Staton and Nicole Gastala
    Citation: Addiction Science & Clinical Practice 2022 17:41
  28. People with opioid use disorder experience high burden of disease from medical comorbidities and are increasingly hospitalized with medical complications. Medications for opioid use disorder are an effective, ...

    Authors: Allison J. Ober, Cristina Murray-Krezan, Kimberly Page, Peter D. Friedmann, Karen Chan Osilla, Stephen Ryzewicz, Sergio Huerta, Mia W. Mazer, Isabel Leamon, Gabrielle Messineo, Katherine E. Watkins, Teryl Nuckols and Itai Danovitch
    Citation: Addiction Science & Clinical Practice 2022 17:39
  29. To characterize and address the opioid crisis disproportionately impacting rural U.S. regions.

    Authors: Richard A. Jenkins, Bridget M. Whitney, Robin M. Nance, Todd M. Allen, Hannah L. F. Cooper, Judith Feinberg, Rob Fredericksen, Peter D. Friedmann, Vivian F. Go, Wiley D. Jenkins, P. Todd Korthuis, William C. Miller, Mai T. Pho, Abby E. Rudolph, David W. Seal, Gordon S. Smith…
    Citation: Addiction Science & Clinical Practice 2022 17:38
  30. Internet-delivered cognitive behavioral therapy (ICBT) for alcohol misuse has potential to radically improve access to evidence-based care, and there is a need to investigate ways to optimize its delivery in c...

    Authors: Christopher Sundström, Vanessa Peynenburg, Carly Chadwick, David Thiessen, Andrew Wilhems, Marcie Nugent, Matthew T. Keough, Michael P. Schaub and Heather D. Hadjistavropoulos
    Citation: Addiction Science & Clinical Practice 2022 17:37
  31. The opioid antagonist extended-release naltrexone (XR-NTX) in the treatment of opioid use disorder (OUD) is effective in terms of safety, abstinence from opioid use and retention in treatment. However, it is u...

    Authors: Anne Marciuch, Ida Halvorsen Brenna, Bente Weimand, Kristin Klemmetsby Solli, Lars Tanum, Bente K. Røstad and Bente Birkeland
    Citation: Addiction Science & Clinical Practice 2022 17:36
  32. Though methadone has been shown to effectively treat opioid use disorder, many barriers prevent individuals from accessing and maintaining treatment. Barriers are prevalent in less populated areas where treatm...

    Authors: Emily Pasman, Rachel Kollin, Michael Broman, Guijin Lee, Elizabeth Agius, Jamey J. Lister, Suzanne Brown and Stella M. Resko
    Citation: Addiction Science & Clinical Practice 2022 17:35
  33. Opioid use disorder (OUD) is a serious health condition that is effectively treated with buprenorphine. However, only a minority of people with OUD are able to access buprenorphine. Many access points for bupr...

    Authors: Caleb J. Banta-Green, Mandy D. Owens, Jason R. Williams, Jeanne M. Sears, Anthony S. Floyd, Wendy Williams-Gilbert and Susan Kingston
    Citation: Addiction Science & Clinical Practice 2022 17:34
  34. Despite demonstrated efficacy, medication treatment for opioid use disorder (MOUD) remain inaccessible to many patients, with barriers identified at the individual, clinic and system level. A wide array of imp...

    Authors: Jessica J. Wyse, Katherine Mackey, Travis I. Lovejoy, Devan Kansagara, Anais Tuepker, Adam J. Gordon, P. Todd Korthuis, Anders Herreid-O’Neill, Beth Williams and Benjamin J. Morasco
    Citation: Addiction Science & Clinical Practice 2022 17:32
  35. Pregaming is a high-drink context popular among college students that often leads to elevated blood alcohol levels and negative consequences. Over 15 years of research studies have demonstrated that pregaming ...

    Authors: Eric R. Pedersen, Justin F. Hummer, Jordan P. Davis, Reagan E. Fitzke, Nina C. Christie, Katie Witkiewitz and John D. Clapp
    Citation: Addiction Science & Clinical Practice 2022 17:31
  36. Until recently, few carceral facilities offered medications for opioid use disorder (MOUD). Although more facilities are adopting MOUD, much remains to be learned about addressing implementation challenges rel...

    Authors: Noa Krawczyk, Sachini Bandara, Sydney Merritt, Hridika Shah, Alexandra Duncan, Brendan McEntee, Maria Schiff, N. Jia Ahmad, Sara Whaley, Amanda Latimore and Brendan Saloner
    Citation: Addiction Science & Clinical Practice 2022 17:30
  37. A cessation program for hospitalized smokers is an effective strategy to achieve smoking abstinence. The effects of multiple in-hospital counseling sessions on 6-month smoking abstinence require further invest...

    Authors: Chin-Wei Kuo, Chuan-Yu Chen, Chih-Hsing Wu, Chang-Wen Chen, Fei-Ran Guo and Szu-Chun Yang
    Citation: Addiction Science & Clinical Practice 2022 17:29
  38. The 2016 U.S. Centers for Disease Control Opioid Prescribing Guideline (CDC Guideline) is currently being revised amid concern that it may be harmful to people with chronic pain on long-term opioid therapy (CP...

    Authors: Gabriela Cedillo, Mary Catherine George, Richa Deshpande, Emma K. T. Benn, Allison Navis, Alexandra Nmashie, Alina Siddiqui, Bridget R. Mueller, Yosuke Chikamoto, Linda Weiss, Maya Scherer, Alexandra Kamler, Judith A. Aberg, Barbara G. Vickrey, Angela Bryan, Brady Horn…
    Citation: Addiction Science & Clinical Practice 2022 17:28
  39. Subcutaneously retained needle fragments in people who inject drugs (PWIDs) are a possible cause of local symptoms, most commonly pain and infections. It remains unknown how common retained needle fragments ar...

    Authors: Heidi Laukkala, Otso Arponen, Mika O Murto and Olli PO Nevalainen
    Citation: Addiction Science & Clinical Practice 2022 17:27
  40. Social networks may play positive and negative roles in the lives of young adults experiencing homelessness (YEH) who are transitioning into housing. Social networks can influence their alcohol and/or other dr...

    Authors: David P. Kennedy, Karen Chan Osilla and Joan S. Tucker
    Citation: Addiction Science & Clinical Practice 2022 17:26
  41. Drug overdose rates in the United States have been steadily increasing, particularly in rural areas. The COVID-19 pandemic and associated mitigation strategies may have increased overdose risk for people who u...

    Authors: Suzan M. Walters, Rebecca S. Bolinski, Ellen Almirol, Stacy Grundy, Scott Fletcher, John Schneider, Samuel R. Friedman, Lawrence J. Ouellet, Danielle C. Ompad, Wiley Jenkins and Mai T. Pho
    Citation: Addiction Science & Clinical Practice 2022 17:24
  42. Opioid use disorders (OUD), co-occurring with either depression and/or PTSD, are prevalent, burdensome, and often receive little or low-quality care. Collaborative care is a service delivery intervention that ...

    Authors: Karen Chan Osilla, Alex R. Dopp, Katherine E. Watkins, Venice Ceballos, Brian Hurley, Lisa S. Meredith, Isabel Leamon, Vanessa Jacobsohn and Miriam Komaromy
    Citation: Addiction Science & Clinical Practice 2022 17:25
  43. Aboriginal and Torres Strait Islander (‘Indigenous’) Australians experience a greater burden of disease from alcohol consumption than non-Indigenous peoples. Brief interventions can help people reduce their co...

    Authors: James H. Conigrave, K. S. Kylie Lee, Paul S. Haber, Julia Vnuk, Michael F. Doyle and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2022 17:23
  44. An increasing number of individuals who use drugs in North America are preferentially consuming fentanyl over other opioids. This has significant consequences on the treatment and management of opioid use diso...

    Authors: Pouya Azar, Jean N. Westenberg, Martha J. Ignaszewski, James S. H. Wong, George Isac, Nickie Mathew and R. Michael Krausz
    Citation: Addiction Science & Clinical Practice 2022 17:22
  45. Authors: Joanne G. Patterson, Tia N. Borger, Jessica L. Burris, Mark Conaway, Robert Klesges, Amie Ashcraft, Lindsay Hauser, Connie Clark, Lauren Wright, Sarah Cooper, Merry C. Smith, Mark Dignan, Stephenie Kennedy-Rea, Electra D. Paskett, Roger Anderson and Amy K. Ferketich
    Citation: Addiction Science & Clinical Practice 2022 17:21

    The original article was published in Addiction Science & Clinical Practice 2022 17:11

  46. Alcohol use increases risk for morbidity and mortality and is associated with over 3 million annual deaths worldwide. Contingency Management (CM) is one of the most effective interventions for substance use di...

    Authors: Crystal L. Smith, Nicole M. Rodin, Julie Y. Hwang, André Q. C. Miguel, Kim Johnson, Michael G. McDonell and Sterling M. McPherson
    Citation: Addiction Science & Clinical Practice 2022 17:20
  47. Disadvantage and transgenerational trauma contribute to Aboriginal and Torres Strait Islander (Indigenous) Australians being more likely to experience adverse health consequences from alcohol and other drug us...

    Authors: James H. Conigrave, Scott Wilson, Katherine M. Conigrave, Tanya Chikritzhs, Noel Hayman, Angela Dawson, Robert Ali, Jimmy Perry, Michelle S. Fitts, Louisa Degenhardt, Michael Doyle, Sonya Egert, Tim Slade, Nadine Ezard, Monika Dzidowska and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2022 17:17

Affiliated with

Annual Journal Metrics

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.